ArticleUrologie (Heidelberg, Germany)2026
[Validation of a new portable measurement method for home use-a feasibility study].
Article in Urologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLower urinary tract symptoms (LUTS), kidney, and bladder diseases are among the most common diseases in men. Despite numerous educational measures, men do not participate in preventive medical checkups or early detection measures. The current study aims to examine whether men can also carry out early detection measures in their home environment. Since men are particularly receptive to digital media, a digital measuring device for home use (the Streamcheck®, SC; Vierkirchen, Germany) was developed that includes important diagnostic measures such as uroflow, biomarkers, and standard questionnaires.
objectiveThe aim of the study was to evaluate SC in a clinical trial under home conditions. MATERIALS AND
methodsA total of 92 men between the ages of 23 and 89 were included and examined with the SC. The urine flow curve, urine volume, micturition time, and biomarkers were recorded. Patient satisfaction was assessed using questionnaires.
resultsThe findings of 73 patients were evaluated. A urine flow curve was obtained for all men with comparable urine volumes (mean: SC = 360 ml, control = 364 ml) and micturition time (maximum difference 4.8%; n. s.). The biomarkers were detected with 100% sensitivity and >95% specificity. The men were very satisfied with the SC, with an average score of 4.04 points (1 = dissatisfied, 5 = very satisfied).
conclusionThe SC has been confirmed as a reliable measurement method for home use with high patient satisfaction. The extent to which the results influence patient behavior with regard to consulting a physician will be investigated in a subsequent study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.